gaboxadol has been researched along with Idiopathic Parkinson Disease in 1 studies
gaboxadol: GABA agonist; inhibitor of GABA uptake systems; structure
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennett, JP | 1 |
| Ferrari, MB | 1 |
| Cruz, CJ | 1 |
1 other study available for gaboxadol and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
GABA-mimetic drugs enhance apomorphine-induced contralateral turning in rats with unilateral nigrostriatal dopamine denervation: implications for the therapy of Parkinson's disease.
Topics: Alkynes; Aminocaproates; Animals; Antiparkinson Agents; Apomorphine; Drug Synergism; gamma-Aminobuty | 1987 |